Comprehensive in-house development capabilities
Formycon’s unique advantage: The proven know-how of its scientists, senior management and advisory board.
Formycon is a leading and independent developer of biosimilar drugs, meeting the highest quality standards, for marketing and distribution around the globe. The company spans the entire pharmaceutical value creation chain all the way through to phase III clinical trials and registration.
Formycon specifically develops biosimilars to meet the stringent standards required for regulatory approval in the most highly regulated markets (EU, U.S., Japan, Canada, Australia), and positions itself as preferred partner for major pharmaceutical and generic corporations.
The extraordinary value-added of Formycon is the know-how of its scientists, its senior management and its advisory board. They have already demonstrated success in their career in bringing the world’s first biosimilars to market, and have unique expertise across all stages of the drug development process – from market analysis and protein analytics, to the development of production processes and clinical development, all the way to registration.
Formycon carries out all stages of development, enabling more rapid results and thus earlier market entry.